Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Is it right to look for anti-cancer drugs amongst compounds having antioxidant effect?

Abdollahi M, Shetab-Boushehri SV.

Daru. 2012 Oct 20;20(1):61. doi: 10.1186/2008-2231-20-61. No abstract available.

2.

Intracellular signaling pathways modulated by phenolic compounds: application for new anti-inflammatory drugs discovery.

Costa G, Francisco V, Lopes MC, Cruz MT, Batista MT.

Curr Med Chem. 2012;19(18):2876-900. Review.

PMID:
22519398
3.

Natural polyphenols as proteasome modulators and their role as anti-cancer compounds.

Bonfili L, Cecarini V, Amici M, Cuccioloni M, Angeletti M, Keller JN, Eleuteri AM.

FEBS J. 2008 Nov;275(22):5512-26. doi: 10.1111/j.1742-4658.2008.06696.x. Review.

4.

Synthesis of novel Schiff base analogues of 4-amino-1,5-dimethyl-2-phenylpyrazol-3-one and their evaluation for antioxidant and anti-inflammatory activity.

Alam MS, Choi JH, Lee DU.

Bioorg Med Chem. 2012 Jul 1;20(13):4103-8. doi: 10.1016/j.bmc.2012.04.058. Epub 2012 May 4.

PMID:
22626550
5.

Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.

Pereg D, Lishner M.

J Intern Med. 2005 Aug;258(2):115-23. Review.

6.

Thiazolidinediones : A class of pharmacologically important molecules.

Aher SB, Auti PB, Washimkar MH.

Mini Rev Med Chem. 2013 Jan 7. [Epub ahead of print]

PMID:
23305399
7.

Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs.

Kourounakis PN, Tsiakitzis K, Kourounakis AP, Galanakis D.

Toxicology. 2000 Apr 3;144(1-3):205-10.

PMID:
10781889
8.

Antioxidant and anti-proliferative properties of lycopene.

Kelkel M, Schumacher M, Dicato M, Diederich M.

Free Radic Res. 2011 Aug;45(8):925-40. doi: 10.3109/10715762.2011.564168. Epub 2011 May 26. Review.

PMID:
21615277
10.

Cancer Drug Development: New Targets for Cancer Treatment.

Curt GA.

Oncologist. 1996;1(3):II-III.

PMID:
10387987
11.
12.
13.
14.

Metals and metal compounds in cancer treatment.

Desoize B.

Anticancer Res. 2004 May-Jun;24(3a):1529-44. Review.

15.

Antioxidant and anti-inflammatory activities of selected medicinal plants and fungi containing phenolic and flavonoid compounds.

Diaz P, Jeong SC, Lee S, Khoo C, Koyyalamudi SR.

Chin Med. 2012 Nov 24;7(1):26. doi: 10.1186/1749-8546-7-26.

16.

Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity.

Suzuki K, Nagasawa H, Uto Y, Sugimoto Y, Noguchi K, Wakida M, Wierzba K, Terada T, Asao T, Yamada Y, Kitazato K, Hori H.

Bioorg Med Chem. 2005 Jun 2;13(12):4014-21.

PMID:
15911314
17.

New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.

Caponigro F, Basile M, de Rosa V, Normanno N.

Anticancer Drugs. 2005 Feb;16(2):211-21.

PMID:
15655420
19.
20.

Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence.

Dasgupta K, Di Cesar D, Ghosn J, Rajan R, Mahmud S, Rahme E.

Cancer J. 2006 Mar-Apr;12(2):130-5.

PMID:
16630404

Supplemental Content

Support Center